According to FutureWise analysis, the market for Acute Repetitive Seizures is estimated to grow at a CAGR of 48% over the forecast period of 2023-2031.
Acute repetitive seizures, more commonly known as cluster, crescendo, or sequential seizures, are outbreaks of increased seizure activity occurring in individuals with refractory epilepsy who are already receiving a stable protocol of anticonvulsants. They lie in the seizure spectrum between isolated seizures and status epilepticus. If acute repetitive seizures are left untreated, they may progress to status epilepticus. Acute repetitive seizures are rated a neurological emergency, and treatment must be prompt. The primary goals of therapy are cessation of the seizure and prevention of recurrence. The use of traditional intravenous agents such as phenytoin, phenobarbital, lorazepam, and diazepam is well-established in the first-line treatment of acute seizures. However, adverse effects and the time to onset of effect often dictate the choice between older anticonvulsants. Newer agents and alternative routes of administration have been developed to reduce adverse effects, decrease the time to onset of effect, reduce acute care facility costs and investigate the possibility of home treatment.
Treatment should only be administered by caregivers in the opinion of the prescriber and are capable of monitoring the clinical response. Caregivers should possess confidence in their ability to identify the appropriate timing and method of treatment. The prescriber and caregiver should have a documented plan on when to treat and what to observe and post-treatment actions . The most immediate treatment for out-of-hospital care and the only U.S. FDA-approved product for acute repetitive seizures is rectal diazepam gel administered within a range of 0.2 to 0.5 mg/kg, based on age and weight. Treatment may lead to a state of central nervous system depression.
FutureWise Market Research has published a report that provides an insightful analysis acute repetitive seizures market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, acute repetitive seizures market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.